Adar1 Capital Management, LLC Renovo Rx, Inc. Transaction History
Adar1 Capital Management, LLC
- $652 Billion
- Q2 2025
A detailed history of Adar1 Capital Management, LLC transactions in Renovo Rx, Inc. stock. As of the latest transaction made, Adar1 Capital Management, LLC holds 19,889 shares of RNXT stock, worth $21,877. This represents 0.0% of its overall portfolio holdings.
Number of Shares
19,889
Previous 479,883
95.86%
Holding current value
$21,877
Previous $475 Million
94.49%
% of portfolio
0.0%
Previous 0.09%
Shares
5 transactions
Others Institutions Holding RNXT
# of Institutions
28Shares Held
9.77MCall Options Held
0Put Options Held
0-
Aigh Capital Management LLC Baltimore, MD3.47MShares$3.81 Million2.59% of portfolio
-
Awm Investment Company, Inc. New York, NY1.87MShares$2.06 Million0.35% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.66MShares$1.83 Million0.0% of portfolio
-
Bank Of The West975KShares$1.07 Million0.27% of portfolio
-
Bleichroeder LP New York, NY500KShares$550,0000.21% of portfolio
About RenovoRx, Inc.
- Ticker RNXT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 9,066,860
- Market Cap $9.97M
- Description
- RenovoRx, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for the treatment of solid tumors. Its lead product candidate is RenovoGem, a drug and device combination consisting of intra-arterial gemcitabine and RenovoCath that is in Phase III clinical trials for the locally advanced pancreatic cancer. RenovoRx, In...